Nan Li1, Yahui Zheng2, Chouhui Xuan2, Zhenhua Lin1, Longzhen Piao3, Shuangping Liu1. 1. Key Laboratory Nature Resources of Changbai Mountain & Functional Molecules, Ministry Education, Yanbian University Yanji 133002, Jilin, China ; Department of Pathology & Cancer Research Center, Yanbian University Medical College Yanji 133002, Jilin, China. 2. Department of Pathology & Cancer Research Center, Yanbian University Medical College Yanji 133002, Jilin, China. 3. Key Laboratory Nature Resources of Changbai Mountain & Functional Molecules, Ministry Education, Yanbian University Yanji 133002, Jilin, China ; Department of Oncology, Yanbian University Hospital Yanji 133002, Jilin, China.
Abstract
BACKGROUND: Leucine zipper/EF hand-containing transmembrane-1 (LETM1) is a mitochondrial inner membrane protein that was first identified in Wolf-Hirschhorn syndrome. However, high-level expression of LETM1 has been correlated with multiple human malignancies, suggesting roles in carcinogenesis and tumor progression. This study is aimed to explore the clinicopathological characteristics and prognostic value of LETM1 overexpression in breast cancer. METHODS: Immunohistochemical (IHC) staining, and immunofluorescence (IF) were performed to examine LETM1 expression in breast cancer cell line/tissues compared with adjacent normal tissues. Statistical analysis was applied to evaluate the correlation between LETM1 overexpression and the clinicopathological features of breast cancer. Survival rates were calculated using the Kaplan-Meier method, and the relationship between prognostic factors and patient survival was analyzed using the Cox proportional hazard models. RESULTS: LETM1 protein showed cytoplasmic staining pattern in breast cancer. The strongly positive rate of LETM1 protein was 61.6% (98/159) in breast cancer, which was significantly higher than in DCIS (29.7%, 11/37), hyperplasia (16.7%, 3/18) and adjacent normal breast tissues (15.9%, 7/44). High-level expression of LETM1 protein was correlated with lymph node metastasis, poor differentiation, late clinical stage, disease-free survival (DFS) and overall survival (OS) rates in breast cancer. Moreover, multivariate analysis suggested that LETM1 emerged as a significant independent prognostic factor along with clinical stage of patients with breast cancer. CONCLUSIONS: LETM1 plays an important role in the progression of breast cancer. High level expression of LETM1 is an independent poor prognostic factor of breast cancer.
BACKGROUND:Leucine zipper/EF hand-containing transmembrane-1 (LETM1) is a mitochondrial inner membrane protein that was first identified in Wolf-Hirschhorn syndrome. However, high-level expression of LETM1 has been correlated with multiple humanmalignancies, suggesting roles in carcinogenesis and tumor progression. This study is aimed to explore the clinicopathological characteristics and prognostic value of LETM1 overexpression in breast cancer. METHODS: Immunohistochemical (IHC) staining, and immunofluorescence (IF) were performed to examine LETM1 expression in breast cancer cell line/tissues compared with adjacent normal tissues. Statistical analysis was applied to evaluate the correlation between LETM1 overexpression and the clinicopathological features of breast cancer. Survival rates were calculated using the Kaplan-Meier method, and the relationship between prognostic factors and patient survival was analyzed using the Cox proportional hazard models. RESULTS:LETM1 protein showed cytoplasmic staining pattern in breast cancer. The strongly positive rate of LETM1 protein was 61.6% (98/159) in breast cancer, which was significantly higher than in DCIS (29.7%, 11/37), hyperplasia (16.7%, 3/18) and adjacent normal breast tissues (15.9%, 7/44). High-level expression of LETM1 protein was correlated with lymph node metastasis, poor differentiation, late clinical stage, disease-free survival (DFS) and overall survival (OS) rates in breast cancer. Moreover, multivariate analysis suggested that LETM1 emerged as a significant independent prognostic factor along with clinical stage of patients with breast cancer. CONCLUSIONS:LETM1 plays an important role in the progression of breast cancer. High level expression of LETM1 is an independent poor prognostic factor of breast cancer.
Entities:
Keywords:
LETM1; breast cancer; immunohistochemistry
Authors: Alison T Stopeck; Ursa Brown-Glaberman; Hong Yuen Wong; Ben Ho Park; Sara E Barnato; William J Gradishar; Clifford A Hudis; Hope S Rugo Journal: Clin Exp Metastasis Date: 2012-06-13 Impact factor: 5.150
Authors: Longzhen Piao; Yuwen Li; Soung Jung Kim; Hee Sun Byun; Song Mei Huang; Soon-Kyung Hwang; Keum-Jin Yang; Kyeong Ah Park; Minho Won; Janghee Hong; Gang Min Hur; Jeong Ho Seok; Minho Shong; Myung-Haing Cho; Derek P Brazil; Brian A Hemmings; Jongsun Park Journal: Cancer Res Date: 2009-03-24 Impact factor: 12.701
Authors: J-Y Shin; Y-S Chung; B Kang; H-L Jiang; D-Y Yu; K Han; C Chae; J-H Moon; G Jang; M-H Cho Journal: Cancer Gene Ther Date: 2013-02-08 Impact factor: 5.987
Authors: Ann E Frazier; Rebecca D Taylor; David U Mick; Bettina Warscheid; Nadine Stoepel; Helmut E Meyer; Michael T Ryan; Bernard Guiard; Peter Rehling Journal: J Cell Biol Date: 2006-02-13 Impact factor: 10.539